Maria Boscacci’s research while affiliated with University of Milan and other places

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (11)


P.0292 Psychiatric and non-psychiatric drugs responsible for false positive amphetamines results on urine test: an up-to-date overview of the literature
  • Article

December 2021

·

58 Reads

European Neuropsychopharmacology

·

M. Boscacci

·

V. Battini

·

[...]

·

E. Clementi

Citations (3)


... 528). While one study estimated that one in two OCD patients benefited from antipsychotics (Conti et al., 2024), a more recent review found efficacy in only one in three patients (Thamby & Jaisoorya, 2019). Indeed, a recent Cochrane review (Komossa et al., 2010) found no effect of olanzapine augmentation on OCD and only some (not fully conclusive) evidence that adding quetiapine or risperidone to antidepressants increases efficacy. ...

Reference:

Towards the DSM-6: The Intersection of OCD and Psychosis: Expert Perspectives on Insight in the Diagnosis of OCD
The use of antipsychotics in obsessive compulsive disorder
  • Citing Article
  • February 2024

Human Psychopharmacology Clinical and Experimental

... Thus, identifying and managing the most critical side effects encourages patients to take medications regularly and adhere to the course of treatment. This situation increases treatment compliance and may positively affect treatment outcomes [10]. Therefore, priority should be given to the more important ones, among these side effects. ...

Psychiatric and non-psychiatric drugs causing false positive amphetamines urine test in psychiatric patients: a pharmacovigilance analysis using FAERS
  • Citing Article
  • May 2023

... In accordance with the literature, a score of 10 or above is a reliable cut-off to assign a provisional diagnosis of major depression [26]. The PHQ-9 has been largely used as a screening tool for depression in primary care settings, as well as to assess depressive symptoms in healthcare workers during COVID-19 [27,28]. ...

The Impact of COVID-19 Pandemic First Wave on Healthcare Workers: A New Perspective from Qualifying PTSD Criterion A to Assessing Post-Traumatic Growth
  • Citing Article
  • Full-text available
  • February 2023